Search All News
Like what the AIDS activists sought in the 80s and 90s, an “opioid movement” may be required for treatments to become acceptable to—and demanded by—communities throughout the United States.
ICAP launched the world’s first multi-country HIV treatment program in 2003 and has helped bring life-saving treatment to nearly 1.5 million people in resource-poor regions around the world.
- July 11, 2018
Frequent hand washing and house cleaning reduce exposure to common flame-retardant chemicals that have been linked to infertility, a new Mailman study has found.
- June 21, 2018
Survivors of opioid overdose are more likely to die from respiratory diseases, viral hepatitis, and suicide—in addition to drug-related causes—than non-drug users, says a new study from Columbia Psychiatry.
- May 25, 2018
Mailman researchers have found that the grandchildren of women who used DES during pregnancy were 36 percent more likely to have ADHD.
- April 20, 2018
A Mailman study of New York City mice found that they harbor multiple pathogenic bacteria, including some with an array of antimicrobial resistance genes.
- April 16, 2018
Childhood exposure to flame retardant chemicals has declined—but not disappeared—since a 2004 phaseout of PBDEs in consumer products, Mailman researchers have found.
- April 6, 2018
With a new grant from the U.S. President’s Malaria Initiative, Mailman’s ICAP will support the implementation of quality malaria diagnosis and treatment services in Ethiopia.
- March 6, 2018
The working group will help Columbia scientists and physicians make their expertise available to policymakers involved in global health security.
- March 1, 2018
Mailman scientists have developed a system that accurately predicts—six weeks in advance—the geographic spread of seasonal influenza in the United States.